M. Haim Erder

3.0k total citations · 1 hit paper
71 papers, 2.2k citations indexed

About

M. Haim Erder is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, M. Haim Erder has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 13 papers in Clinical Psychology. Recurrent topics in M. Haim Erder's work include Attention Deficit Hyperactivity Disorder (38 papers), Treatment of Major Depression (14 papers) and Child and Adolescent Psychosocial and Emotional Development (12 papers). M. Haim Erder is often cited by papers focused on Attention Deficit Hyperactivity Disorder (38 papers), Treatment of Major Depression (14 papers) and Child and Adolescent Psychosocial and Emotional Development (12 papers). M. Haim Erder collaborates with scholars based in United States, United Kingdom and Germany. M. Haim Erder's co-authors include Paul Hodgkins, Vanja Sikirica, Juliana Setyawan, Eric Q. Wu, Jipan Xie, Jennifer Kahle, Jalpa A. Doshi, James Signorovitch, Mei Lü and Keith A. Betts and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Journal of Affective Disorders and Epilepsia.

In The Last Decade

M. Haim Erder

67 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy

2013 284 citations Paul Hodgkins, M. Haim Erder et al. profile →

Peers

Countries citing papers authored by M. Haim Erder

Since Specialization

Citations

This map shows the geographic impact of M. Haim Erder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Haim Erder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Haim Erder more than expected).

Fields of papers citing papers by M. Haim Erder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Haim Erder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Haim Erder. The network helps show where M. Haim Erder may publish in the future.

Co-authorship network of co-authors of M. Haim Erder

This figure shows the co-authorship network connecting the top 25 collaborators of M. Haim Erder. A scholar is included among the top collaborators of M. Haim Erder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Haim Erder. M. Haim Erder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges of Developing an Observable Parent-Reported Measure: A Qualitative Study of Functional Impact of ADHD in Children 2017 ·Value in Health ·Louis S. Matza, Mary Kay Margolis, Linda S. Deal, Kimberly F Farrand, M. Haim Erder	7
2	Estimating the Prevalence of Binge Eating Disorder in a Community Sample From the United States 2016 ·The Journal of Clinical Psychiatry ·Nicole Cossrow, Manjiri Pawaskar, Edward A. Witt, Eileen E. Ming, Timothy W. Victor, Barry K. Herman, Thomas A. Wadden, M. Haim Erder	88
3	The Caregiver Perspective on Paediatric ADHD (CAPPA) survey: Understanding sociodemographic and clinical characteristics, treatment use and impact of ADHD in Europe 2016 ·Journal of Affective Disorders ·Emuella Flood, Kavita Gajria, Vanja Sikirica, Camila Dietrich, (unknown), Valerie Harpin, Tobias Banaschewski, Javier Quintero, M. Haim Erder, Moshe Fridman, Kristina Chen	20
4	Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder 2015 ·Health and Quality of Life Outcomes ·Kavita Gajria, Mark Kosinski, Vanja Sikirica, Michael Huß, Elayne Livote, Kathleen H. Reilly, Regina Dittmann, M. Haim Erder	60
5	Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis 2015 ·European Psychiatry ·Moshe Fridman, P. Hodgkins, Jennifer Kahle, M. Haim Erder	13
6	Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder 2015 ·Value in Health ·Juliana Setyawan, Hongbo Yang, David Cheng, Xiaopeng Cai, James Signorovitch, Jipan Xie, M. Haim Erder	6
7	Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective 2014 ·ADHD Attention Deficit and Hyperactivity Disorders ·Juliana Setyawan, Moshe Fridman, Paul Hodgkins, Javier Quintero, M. Haim Erder, Božena Katić, Valerie Harpin	6
8	Immediate-Release Versus Extended-Release Guanfacine for Treatment of Attention-Deficit/Hyperactivity Disorder 2013 ·The American Journal of Managed Care ·Vanja Sikirica, Jipan Xie, (unknown), M. Haim Erder, Paul Hodgkins, Hongbo Yang, (unknown), (unknown)	6
9	Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis 2013 ·Journal of Medical Economics ·Juliana Setyawan, Paul Hodgkins, Annie Guérin, Geneviève Gauthier, Martin Cloutier, Eric Q. Wu, M. Haim Erder	18
10	Development of a conceptual disease model to inform strategy to evaluate treatment impact in adolescents with attention deficit hyperactivity disorder (ADHD) 2013 ·Value in Health ·Robin Pokrzywinski, Juliana Setyawan, (unknown), M. Haim Erder, P. Hodgkins, Asha Hareendran	2
11	Development Of Patient-Reported Outcomes (Pro) And Observer-Reported Outcomes (Obsro) Measures For Pediatric Ulcerative Colitis: Concept Elicitation Findings 2013 ·Value in Health ·(unknown), Emuella Flood, (unknown), Jennifer Tucker, (unknown), (unknown), Debra G. Silberg, M. Haim Erder	1
12	Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults 2013 ·Journal of Medical Economics ·Juliana Setyawan, Paul Hodgkins, Annie Guérin, Geneviève Gauthier, Martin Cloutier, Eric Q. Wu, M. Haim Erder	5
13	Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population. 2012 ·PubMed ·Eric Q. Wu, Rym Ben-Hamadi, Mei Lü, (unknown), Andrew P. Yu, M. Haim Erder	0
14	Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents 2012 ·PharmacoEconomics ·Vanja Sikirica, M. Haim Erder, Jipan Xie, Dendy Macaulay, (unknown), Paul Hodgkins, Eric Q. Wu	23
15	Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity 2012 ·Journal of Medical Economics ·M. Haim Erder, James Signorovitch, Juliana Setyawan, Hongbo Yang, Kejal Parikh, Keith A. Betts, Jipan Xie, Paul Hodgkins, Eric Q. Wu	7
16	Economic Impact of Childhood and Adult Attention-Deficit/Hyperactivity Disorder in the United States 2012 ·Journal of the American Academy of Child & Adolescent Psychiatry ·Jalpa A. Doshi, Paul Hodgkins, Jennifer Kahle, Vanja Sikirica, Michael J. Cangelosi, Juliana Setyawan, M. Haim Erder, Peter J. Neumann	338
17	Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research 2012 ·Value in Health ·James Signorovitch, Vanja Sikirica, M. Haim Erder, Jipan Xie, Mei Lü, Paul Hodgkins, Keith A. Betts, Eric Q. Wu	310
18	PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS 2011 ·Value in Health ·M. Haim Erder, (unknown), E.Q. Wu, P. Hodgkins, Vanja Sikirica	1
19	Memantine Discontinuation and the Health Status of Nursing Home Residents With Alzheimer's Disease 2010 ·Journal of the American Medical Directors Association ·Howard Fillit, Robert K. Hofbauer, Juliana Setyawan, Stavros Tourkodimitris, Moshe Fridman, Vojislav Pejović, M. L. Miller, M. Haim Erder, Constantine G. Lyketsos	10
20	Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs 2009 ·Journal of Medical Economics ·Eric Q. Wu, RN, (unknown), Andrew P. Yu, Rym Ben-Hamadi, M. Haim Erder	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact